Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-05

Clinical Trial Update: Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF [NA]

View source ↗

Summary

Clinical trial update for Jin-shui Huan-xian Formula to slow pulmonary function decline in idiopathic pulmonary fibrosis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jin-shui Huan-xian Formula

Snippet

Sponsor: Henan University of Traditional Chinese Medicine | Conditions: Idiopathic Pulmonary Fibrosis(IPF) | NA | Status: NOT_YET_RECRUITING